instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Inquiry and feedback about Product A and Product B
BODY:
Dear Clinical Affairs,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected patients. and I am writing to formally report two distinct matters. Regarding Product A I need to con... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require premedicatio... |
SUBJECT: Urgent concern regarding Product A and institutional contract enquiry
BODY:
Dear Medical Information and Safety Team,
As the formulary coordinator for a 300-bed community hospital and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure patients during handling in a specific identified b... |
SUBJECT: Integrated feedback regarding Product A and institutional inquiry
BODY:
Dear Quality Assurance Team,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisor... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug interactio... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Quality and Commercial Teams,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. I have two distinct problems to raise.... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient noticed yellowing of sclera and skin suggestive of hepatic involvement after 10 days temporally associated with Product A initiation, wi... |
SUBJECT: Inquiry and feedback about Product A and supply inquiry
BODY:
Dear Quality Officer,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 33 year old female with multiple... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Multi-product safety and information request for Product A and institutional contract enquiry
BODY:
Dear Drug Safety and Medical Information,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to formally raise two separate matters. The first is a product quality matter iden... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the solution appeared cloudy with visible particulate matter that was not described in the product leaflet in a specific identified bat... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Patient Support,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. I have two distinct concerns to raise. The first is an adverse reaction my pati... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed new-onset atrial fibrillation within 72 hours temporally associated with Product A initiation, with clinical intervention and ... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Pharmacy Director,
I am the director of pharmacy for a network of community hospitals and I have two distinct issues to address. Regarding Product A for formulary evaluation, What is the recommended starting dose for Product A in patients... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I need to address two separate issues. Regarding Product A our... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailab... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Quality Officer,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. I have two separate matters to raise. Firstly regarding P... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the subject-reported o... |
SUBJECT: Supply and experience review of Product A and institutional contract enquiry
BODY:
Dear Patient Support,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dis... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the outer box was water-damaged during transit, affecting the legibility of dosage instructions printed on the flap in a specific ident... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Medical and Commercial Teams,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected patients. and I need to address two separate issues. Regarding Product A... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recomm... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I wish to raise two issues simultaneously... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient observed hallucinations and confusion beginning on day 4 of the regimen temporally associated with Product A initiation, with clinical i... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Medical Director,
I am the business development lead at MedCore Partners exploring joint procurement initiatives for Product A in nephrology and Product B in hepatology. and I am writing to formally report two distinct matters. Regarding Product A I... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
To Whom It May Concern,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am writing to formally report two distinct matters. Regarding Produ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there a black box warning or reg... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
Dear Pharmacovigilance Team,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where several tablets were chipped along the edges and had an off-white discoloration inconsistent with the product specification in a specif... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
Our outindividual clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. I have two separate matters to raise. Firstly re... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on ... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Post-Market Surveillance,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I wish to raise two issues ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinica... |
SUBJECT: Inquiry and feedback about Product A and institutional contract enquiry
BODY:
Dear Clinical Coordinator,
I am the chief pharmacist at a district general hospital and I am writing to formally raise two separate matters. The first is a product quality problem identified during routine dispensing inspection of o... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the powder for reconstitution formed clumps that did not dissolve completely after 5 minutes of shaking in a specific identified batch ... |
SUBJECT: Unexpected reaction linked to Product A and institutional contract enquiry
BODY:
Dear Regulatory Affairs,
As the head of pharmacy procurement for a regional health trust and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspect... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where a vial arrived with a cracked neck, causing leakage of approximately 2 ml of solution in a specific identified batch with quarantined s... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Quality and Commercial Teams,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I am writing to report two separate issues. The first involves Pr... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the individual reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical in... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Drug Safety Department,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I am writing to formally report two distinct ma... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there any guidance on Product A ... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Patient Support,
I am the head of formulary and medicines optimisation for an integrated care board and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What is the bioequivalenc... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the bioequivalence data for the gene... |
SUBJECT: Patient feedback concerning Product A and supply inquiry
BODY:
Dear Pharmacovigilance Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I have two distinct issues to address. The first concerns Product A where The patient is a 73 year old male with Parkin... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Integrated feedback regarding Product A and supply inquiry
BODY:
Dear Regulatory Affairs,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 28 year old female, 8 weeks post... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. I have two separate concerns to raise. The first is a clinical information ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Patient Support,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. I have two distinct concerns to raise. The first is an advers... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the subject developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinica... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outindividual services. and I am formally reporting two concerns. The first is a safety... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical int... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I am writing to report two separate issues. The first ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from insomnia that progressed to near-total sleep deprivation over 1 week temporally associated with Product A initiation, with... |
SUBJECT: Integrated feedback regarding Product A and institutional contract enquiry
BODY:
Dear Quality Assurance Team,
I am the ward manager on a busy medical unit and I am contacting you regarding two separate topics. The first is a product defect report for Product A where the tablets in the current batch are a visi... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the tablets in the current batch are a visibly darker shade than all previous batches of the same strength in a specific identified bat... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Medical Director,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. and I am writing to formally raise two matters. The first concerns Product ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on Product A u... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Customer Support,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am writing to formally report two distinct matters. Regarding Pro... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
To Whom It May Concern,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am writing to report two separate issues. The first involves Produc... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the individual developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clin... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Healthcare Liaison,
I am writing as the clinical coordinator for a multi-site renal network where Product A is used for anaemia management and Product B for phosphate binding. and I am writing to raise two distinct concerns. The first is a clinical infor... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinica... |
SUBJECT: Complex issue involving Product A and Product B
BODY:
Dear Quality Officer,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. and I wish to bring two issues to your attention. The first is a medical information que... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Patient Support,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I wish to raise two issues simultaneously. The first is an adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the subject developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinica... |
SUBJECT: Integrated feedback regarding Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the ward manager on a busy medical unit and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection of our current Pro... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the adhesive on the secondary label failed, causing it to detach from the primary container surface in a specific identified batch with... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I need to bring two matters to your attenti... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Quality Officer,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. and I wish to raise two issues. The first concerns medical infor... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What monitoring parameters are reco... |
SUBJECT: Pricing inquiry and safety signal for Product A and institutional contract enquiry
BODY:
Dear Drug Safety Department,
I am the director of pharmacy for a network of community hospitals and I have two distinct issues to address. The first concerns Product A 20mg where our quality team found that the ointment t... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the ointment tube was severely swollen, suggesting a reaction between the product and the tube lining in a specific identified batch wi... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Clinical Affairs,
Our outindividual clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I wish to raise two issues simultaneously. The first is an adverse event repo... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
Dear Healthcare Liaison,
I am the nurse practitioner in a busy GP practice and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 36 year old female with generalized anxiety disorder. ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Patient Support,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I am writing to formally report two distinct matters. Regarding Product A I n... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you send any recent peer-revi... |
SUBJECT: Inquiry and feedback about Product A and Product B
BODY:
Dear Medical Information Team,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. I have two separate matters to raise. Firstly regarding Produc... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A have any known intera... |
SUBJECT: Urgent issue regarding Product A and Product B
BODY:
Dear Medical Director,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am writing to raise two distinct concerns. The first is ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Medical and Commercial Teams,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I am contacting you about two separate matters. The f... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Healthcare provider memo on Product A and institutional inquiry
BODY:
Dear Customer Support,
As the pharmacy director of a 500-bed tertiary hospital and I have two distinct issues to address. Regarding Product A for formulary evaluation, What are the documented drug-drug interactions between Product A and com... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug interactio... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Drug Safety Department,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I need to address two separate iss... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity ri... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I am formally reporting two conce... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with... |
SUBJECT: Clinical observation with Product A and supply inquiry
BODY:
Dear Regulatory Affairs,
I am the clinical pharmacist for a long-term care facility and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 76 year old male with polymyalgia rheumatica on c... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention taken, qualify... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Pharmacy Director,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I wish to bring two issues to your attention. The fir... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug in... |
SUBJECT: Issue reported with Product A and supply inquiry
BODY:
Dear Medical Information and Safety Team,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 38 year old femal... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient had a generalized tonic-clonic seizure approximately 12 hours after the evening dose temporally associated with Product A initiation, with clinical ... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am writing to report two separate issues. T... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinica... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the clinical pharmacy specialist in a busy emergency department where Product A is used for rapid anticoagulation reversal and Product B for gastric acid suppression. and I am contacting you about two separate matters.... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Are there any dietary restrictions ... |
SUBJECT: Market access and patient impact of Product A and supply inquiry
BODY:
Dear Drug Safety Department,
I am the lead clinical pharmacist at a regional oncology unit and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 57 year old male with sleep... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical intervention taken, qu... |
SUBJECT: Complex issue involving Product A and institutional contract enquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the quality officer at a private hospital and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the barc... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the barcode on the outer packaging failed to scan at three separate pharmacy workstations in a specific identified batch with quarantin... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. and I wish to bring two issues to your attention. The firs... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and b... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Quality Assurance Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I am writing to report two separate issues. The... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the individual suffered from persistent headaches that increased in intensity over 5 days temporally associated with Product A initiation, with clin... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am writing to raise two distinct concerns. The first is... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recom... |
SUBJECT: Joint product evaluation and safety report for Product A and supply inquiry
BODY:
Dear Medical and Commercial Teams,
I am the clinical lead at a geriatric medicine service and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 31 ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical intervention take... |
SUBJECT: Inquiry and feedback about Product A and supply inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the clinical lead pharmacist at a large teaching hospital and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The individual is a 41... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient suffered from persistent headaches that increased in intensity over 5 days temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Quality Assurance Team,
I am the market access manager evaluating regional coverage for Product A in dermatology and Product B in rheumatology outpatient services. and I need to address two issues simultaneously. The first is a medical information... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide a summary of clinic... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Patient Support,
I am the head of formulary and medicines optimisation for an integrated care board and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 70 year old ma... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient showed signs of acute renal dysfunction with rising creatinine after 5 days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Administrative and medical query on Product A and institutional inquiry
BODY:
Dear Drug Safety Department,
I am the medical director of a specialist cardiovascular centre and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where What is the rec... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I need to address two separat... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the established dosing inter... |
SUBJECT: Patient feedback concerning Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am the clinical pharmacist for a long-term care facility and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 33 year old female with multiple sclerosis ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervention taken, q... |
SUBJECT: Integrated feedback regarding Product A and Product B
BODY:
Dear Post-Market Surveillance,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I need to bring two matters to your attention. Regarding Product A The patie... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. and I am writing to f... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What monitoring parameters are reco... |
SUBJECT: Administrative and medical query on Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I have two distinct issues to address. The first concerns Product A where The patient is a 47 year old male wit... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervention taken, q... |
SUBJECT: Labeling error and clinical query about Product A and Product B
BODY:
Dear Healthcare Liaison,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I am writing to report two separate issues. The first involves Produ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient had a generalized tonic-clonic seizure approximately 12 hours after the evening dose temporally associated with Product A initiation, wi... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Pharmacy Director,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. and I need to address two ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is Product A approved for pediatric... |
SUBJECT: Unexpected reaction linked to Product A and Product B
BODY:
Dear Integrated Quality and Safety Team,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I am formally reporting two matters. The first is a safety issue w... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Distribution and side-effect profile of Product A and institutional inquiry
BODY:
To Whom It May Concern,
I am the medical director of a specialist cardiovascular centre and I have two distinct issues to address. Regarding Product A for formulary evaluation, Please provide the recommended storage temperature ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the recommended storage tempe... |
SUBJECT: Comprehensive inquiry on Product A and supply inquiry
BODY:
Dear Clinical Affairs,
I am the prescribing advisor for a mental health trust and I am writing to formally report two issues. The first is a patient safety issue with Product A where The patient is a 31 year old female with lupus. She developed bilat... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical intervention t... |
SUBJECT: Request for details about Product A and supply inquiry
BODY:
Dear Customer Support,
I am the nurse practitioner in a busy GP practice and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 66 year old male with chronic lymphocytic leukemia in r... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
To Whom It May Concern,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I wish to raise two issues. The first concerns medical informa... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What are the documented drug-drug i... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I wish to raise two issues simultaneously. The first i... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Follow-up needed for Product A and institutional contract enquiry
BODY:
Dear Medical Information and Safety Team,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 50mg where several tablets were c... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where several tablets were chipped along the edges and had an off-white discoloration inconsistent with the product specification in a specif... |
SUBJECT: Urgent concern regarding Product A and institutional contract enquiry
BODY:
Dear Patient Support,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed t... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the inhaler canister appeared dented and the counter mechanism was frozen at 0 doses remaining in a specific identified batch with quar... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Safety Team,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I need to address two separate issues. Regarding Product A our clini... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric ... |
SUBJECT: Combined quality and clinical report for Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am the lead clinical pharmacist at a regional oncology unit and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 55 year old female wit... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Clinical observation with Product A and institutional contract enquiry
BODY:
To Whom It May Concern,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is a quality assurance issue with Product A 50mg where the cartridge contained visible fibri... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where the cartridge contained visible fibrils or precipitate that should not have been present in a specific identified batch with quarantine... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 42... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Co-therapy observation and commercial query on Product A and Product B
BODY:
Dear Pharmacovigilance Team,
I am the medical director of a residential care home group managing over 400 elderly residents across four facilities, several of whom are on Product A for hypertension and Product B for hyperlipidemia. a... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the recommended starting do... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
Our paediatric ward currently uses Product A for seizure control and Product B for adjunctive behavioural management in selected subjects. and I need to bring two matters to your attention. Regarding Product A... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clini... |
SUBJECT: Combined quality and clinical report for Product A and supply inquiry
BODY:
Dear Patient Support,
I am the lead clinical coordinator for a hospice network and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 62 year old female w... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervention taken, q... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I am writing to raise two distinct concerns. The first is a clinical inf... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
Dear Adverse Event Reporting Center,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to raise two separate matters. The first is a clinical information request regarding Product A whi... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dose for Pr... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Quality and Commercial Teams,
I am the prescribing advisor for a mental health trust and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee is... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the infusion instructions if Produc... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Medical Director,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I am writing to raise two distinct concer... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any guidance on dose modifi... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Medical Director,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. I have two separate matters to raise. Firstly regarding ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you send any recent peer-revie... |
SUBJECT: Request for details about Product A and Product B
BODY:
Dear Healthcare Liaison,
Our urgent care centre frequently dispenses Product A for acute migraine and Product B for nausea management in the same patient episodes. and I wish to raise two issues simultaneously. The first is an adverse event report for Pr... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Pharmacovigilance Team,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I am writing to report two separate issues.... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clini... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Integrated Quality and Safety Team,
As the head of pharmacy procurement for a regional health trust and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 28 year old fe... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Customer Support,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I am writing to raise two distinct concerns. The first is ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recom... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Customer Support,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I am writing to formally raise two matters. The first concerns Prod... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in... |
SUBJECT: Pricing inquiry and safety signal for Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am writing to raise two distinct... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recomm... |
SUBJECT: Co-therapy observation and commercial query on Product A and institutional inquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the lead clinical coordinator for a hospice network and I have two distinct issues to address. Regarding Product A for formulary evaluation, What monitoring parameters are ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What monitoring parameters are recommended d... |
SUBJECT: Dual product inquiry and report about Product A and supply inquiry
BODY:
Dear Medical Information and Safety Team,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 38 year old female with... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the individual experienced acute chest pain radiating to the left arm within 4 hours of the dose temporally associated with Product A initiation, with clinical ... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am formally reporting two concerns. The first ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical interventi... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.